Divis Lab (Large Cap - Next Multibagger) Share Target 2024, 2025 To 2039
|
Divi's Laboratories Limited |
|||
|
Price: ₹5,846.75 | ||
| 52 Week Low: ₹3,350.00 52 Week High: ₹6,285.45 |
|||
| Market Capital: 1,56,649.27 Crore (Largecap) | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Divis Lab Share Price Target For 2024
- 1.1.1: Divis Lab Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Divis Lab Share Price Target For 2025
- 1.2.1: Divis Lab Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Divis Lab Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Divis Lab Brief Company Overview
- 4: Divis Lab Financial Performance
- 4.0.1: Is Divis Lab A Good Buy For Long Term?
To predict the Divis Lab's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Divis Lab Share Price Target For 2024
The line chart displays the monthly closing prices of Divis Lab with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Divis Lab shares in 2024, see the table below.
Divis Lab Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 6050.0 (+3.47%) | Price Action: 07 Nov 2024 High |
| 2024 Target 2 | 5988.95 (+2.43%) | Price Action: 27 Nov 2024 Low |
| 2024 Target 1 | 5928.25 (+1.39%) | Price Action: 12 Dec 2024 Low |
| Current Price | 5846.75 | Divis Lab's share price as of 20 Dec 2024 |
| Stop Loss 1 | 5797.0 (-0.86%) | Price Action: 30 Oct 2024 Low |
| Stop Loss 2 | 5723.14 (-2.12%) | Price Action: 14 Nov 2024 Low |
| Stop Loss 3 | 5644.71 (-3.46%) | Fibonacci Retracement Level 28.20% |
Short-Term Technical Outlook
Current Technical Position: Divis Lab is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 50-day moving average at ₹5950.28 serves as the nearest technical reference point.
Historical Returns: 3-month: +7.41% | 6-month: +27.98% | 1-year: +50.69%
Divis Lab Share Price Target For 2025
The line chart displays the monthly closing prices of Divis Lab with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Divis Lab shares in 2025, see the table below.
Divis Lab Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 7986.23 (+36.59%) | Price Action: Chart |
| 2025 Target 2 | 7837.32 (+34.04%) | Price Action: Chart |
| 2025 Target 1 | 7759.72 (+32.71%) | Fibonacci Extension Level 64.90% |
| Current Price | 5846.75 | Divis Lab's share price as of 20 Dec 2024 |
| Stop Loss 1 | 5265.57 (-9.95%) | Price Action: Oct 2021 High |
| Stop Loss 2 | 5199.09 (-11.08%) | Technical Indicator: MA150 |
| Stop Loss 3 | 5129.64 (-12.27%) | Price Action: Nov 2021 High |
Long-Term Technical Outlook
52-Week Range Analysis: Divis Lab is currently trading near its 52-week high of ₹6285.45, showing strong yearly momentum.
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: +50.69% | 3-year: +28.77% | 5-year: +230.14%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Divis Lab Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹5,846.75 | ||
| 2024 | ₹7,006.65 | +19.84% | ₹7,111.75 |
| 2025 | ₹10,269.56 | +46.57% | ₹10,423.60 |
| 2026 | ₹14,078.66 | +37.09% | ₹14,292.88 |
| 2027 | ₹19,291.45 | +37.03% | ₹19,580.82 |
| 2028 | ₹23,562.46 | +22.14% | ₹23,915.90 |
| 2029 | ₹26,211.00 | +11.24% | ₹26,604.16 |
| 2030 | ₹28,450.69 | +8.54% | ₹29,288.61 |
| 2031 | ₹32,485.81 | +14.18% | ₹34,287.18 |
| 2032 | ₹39,285.76 | +20.93% | ₹39,875.05 |
| 2033 | ₹43,790.40 | +11.47% | ₹44,447.26 |
| 2034 | ₹45,415.34 | +3.71% | ₹46,096.57 |
| 2035 | ₹46,631.81 | +2.68% | ₹49,417.15 |
| 2036 | ₹50,892.96 | +9.14% | ₹54,498.05 |
| 2037 | ₹59,280.07 | +16.48% | ₹60,169.27 |
| 2038 | ₹64,018.33 | +7.99% | ₹64,978.60 |
| 2039 | ₹62,559.60 | -2.28% | ₹64,659.86 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Divis Lab Brief Company Overview
Divi's Laboratories Limited: A Leading Pharmaceutical Manufacturer Divi's Laboratories, headquartered in Hyderabad, India, is a reputable manufacturer of: Generic APIs and intermediates Nutraceutical ingredients Carotenoids Vitamins Since its inception in 1990, Divi's has...
expanded its presence globally, catering to industries such as food, dietary supplements, and feed manufacturing. The company's commitment to custom manufacturing and diverse product range has earned it recognition as a leading player in the pharmaceutical sector.Divis Lab Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 1,56,649.27 Crore | Market valuation of Divis Lab's shares. |
| Revenue (TTM) | 8,614 Crore | Total revenue generated by Divis Lab over the past twelve months. |
| Net Income (TTM) | +18,360,000,512.00 | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +26.38% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +21.31% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+22.50% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
+46.60% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
0.05 | Company's total debt divided by total shareholder equity. |
| Total Debt | 8 Crore | Sum of Divis Lab's current & long-term financial obligations. |
| Total Cash | 3,601.99 Crore | Total amount of liquid funds available to Divis Lab. |
| Beta | 0.34 | Beta is less than 1 indicating that the Divis Lab's price is less volatile than the market. |
Is Divis Lab A Good Buy For Long Term?
Divis Lab, a large-cap stock with a substantial market capitalization of ₹1,56,649.27 crore, shows strong financial health. Boasting a healthy profit margin of 21.31% and impressive revenue growth (22.5% QoQ), coupled with a significant cash balance of ₹3,601.99 crore against minimal debt (₹8 crore), indicates robust financial performance. Exceptional returns over various periods, including 77.02% in the past 12 months and a remarkable 304.69% over five years, suggest it's a good buy for long-term investors. However, individual risk tolerance should always be considered.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
